Kolaviron improved resistance to oxidative stress and inflammation in the blood (erythrocyte, serum, and plasma) of streptozotocin-induced diabetic rats

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Ayepola, Omolola R ^a   Brooks, Nicole L ^a   Oguntibeju, Oluwafemi O ^a  

^a CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CHOLESTEROL; GARCINIA KOLA EXTRACT; GLUCOSE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A1C; INTERLEUKIN 1; KOLAVIRON; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYGEN RADICAL; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; VASCULOTROPIN; ANTIOXIDANT; AUTACOID; FLAVONOID; GLYCOSYLATED HEMOGLOBIN; LIPID; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTILIPIDEMIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIOXIDANT ASSAY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; ENZYME ACTIVITY; ERYTHROCYTE; FERRIC REDUCING ANTIOXIDANT POWER; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; INFLAMMATION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; OXYGEN RADICAL ABSORBING CAPACITY; PHARMACOLOGICAL PARAMETERS; PLANT SEED; RAT; REDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; METABOLISM;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; ERYTHROCYTES; FLAVONOIDS; HEMOGLOBIN A, GLYCOSYLATED; INFLAMMATION; INFLAMMATION MEDIATORS; LIPIDS; MALE; OXIDATIVE STRESS; PLANT EXTRACTS; RATS;

EID: 84899414158     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/921080     Document Type: Article

References (60)

1. Baggio L. L., Drucker D. J., Biology of Incretins: GLP-1 and GIP. Gastroenterology 2007 132 6 2131 2157 2-s2.0-34248223285 10.1053/j.gastro.2007. 03.054
2. Brownlee M., Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 6865 813 820 2-s2.0-0035856980 10.1038/414813a
3. Rösen P., Nawroth P. P., King G., Möller W., Tritschler H.-J., Packer L., The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a congress series sponsored by UNESCO-MCBN, the American diabetes association and the German diabetes society. Diabetes/Metabolism Research and Reviews 2001 17 3 189 212 2-s2.0-0034939115 10.1002/dmrr.196
4. Evans J. L., Goldfine I. D., Maddux B. A., Grodsky G. M., Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrine Reviews 2002 23 5 599 622 2-s2.0-0036796875 10.1210/er.2001-0039
5. Bahorun T., Soobrattee M., Luximon-Ramma V., Aruoma O., Free radicals and antioxidants in cardiovascular health and disease. Internet Journal of Medical Update 2006 1 2 25 41
6. Halliwell B., Biochemistry of oxidative stress. Biochemical Society Transactions 2007 35, part 5 1147 1150 2-s2.0-36749010860 10.1042/BST0351147
7. Pandey K. B., Rizvi S. I., Biomarkers of oxidative stress in red blood cells. Biomedical Papers 2011 155 2 131 136 2-s2.0-79960159042 10.5507/bp.2011.027
8. Comazzi S., Spagnolo V., Bonfanti U., Erythrocyte changes in canine diabetes mellitus: in vitro effects of hyperglycaemia and ketoacidosis. Comparative Clinical Pathology 2004 12 4 199 205 2-s2.0-20444422941 10.1007/s00580-004-0502-x
9. Dallak M., Bin-Jaliah I., Antioxidant activity of Citrulluscolocynthis pulp extract in the RBC's of alloxan-induced diabetic rats. Pakistan Journal of Physiology 2010 6 1 112 122
10. Kolanjiappan K., Manoharan S., Kayalvizhi M., Measurement of erythrocyte lipids, lipid peroxidation, antioxidants and osmotic fragility in cervical cancer patients. Clinica Chimica Acta 2002 326 1-2 143 149 2-s2.0-0036889595 10.1016/S0009-8981(02)00300-5
11. Kiritoshi S., Nishikawa T., Sonoda K., Kukidome D., Senokuchi T., Matsuo T., Matsumura T., Tokunaga H., Brownlee M., Araki E., Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes 2003 52 10 2570 2577 2-s2.0-0141755317 10.2337/diabetes.52.10.2570
12. Baynes J. W., Chemical modification of proteins by lipids in diabetes. Clinical Chemistry and Laboratory Medicine 2003 41 9 1159 1165 2-s2.0-0142029557 10.1515/CCLM.2003.179
13. Wolff S. P., Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. British Medical Bulletin 1993 49 3 642 652 2-s2.0-0027279232
14. Griesmacher A., Kindhauser M., Andert S. E., Schreiner W., Toma C., Knoebl P., Pietschmann P., Prager R., Schnack C., Schernthaner G., Mueller M. M., Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. American Journal of Medicine 1995 98 5 469 475 2-s2.0-0029029055 10.1016/S0002-9343(99)80347-7
15. Navarro-González J. F., Mora-Fernández C., de Fuentes M. M., García-Pérez J., Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nature Reviews Nephrology 2011 7 6 327 340 2-s2.0-79957874666 10.1038/nrneph.2011.51
16. Kavey R.-E. W., Allada V., Daniels S. R., Hayman L. L., McCrindle B. W., Newburger J. W., Parekh R. S., Steinberger J., Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association expert panel on population and prevention science; the councils on cardiovascular disease in the young, epidemiology and prevention, nutrition, physical activity and metabolism, high blood pressure research, cardiovascular nursing, and the kidney in heart disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Paediatrics. Circulation 2006 114 24 2710 2738 2-s2.0-33845875445 10.1161/CIRCULATIONAHA.106.179568
17. Terashima K., Takaya Y., Niwa M., Powerful antioxidative agents based on garcinoic acid from Garcinia kola. Bioorganic and Medicinal Chemistry 2002 10 5 1619 1625 2-s2.0-0036189342 10.1016/S0968-0896(01)00428-X
18. Olaleye S. B., Farombi E. O., Adewoye E. A., Owoyele B. V., Onasanwo S. A., Elegbe R. A., Analgesic and anti-inflammatory effects of kolaviron (a Garcinia kola seed extract). African Journal of Biomedical Research 2000 3 171 174
19. Farombi E. O., Adepoju B. F., Ola-Davies O. E., Emerole G. O., Chemoprevention of aflatoxin B1-induced genotoxicity and hepatic oxidative damage in rats by kolaviron, a natural biflavonoid of Garcinia kola seeds. European Journal of Cancer Prevention 2005 14 3 207 214 2-s2.0-20344365598 10.1097/00008469-200506000-00003
20. Farombi E. O., Shrotriya S., Surh Y.-J., Kolaviron inhibits dimethyl nitrosamine-induced liver injury by suppressing COX-2 and iNOS expression via NF- B and AP-1. Life Sciences 2009 84 5-6 149 155 2-s2.0-58149460655 10.1016/j.lfs.2008.11.012
21. Adedara I. A., Farombi E. O., Chemoprotection of ethylene glycol monoethyl ether-induced reproductive toxicity in male rats by kolaviron, isolated biflavonoid from Garcinia kola seed. Human and Experimental Toxicology 2012 31 506 517
22. Farombi E. O., Adedara I. A., Ajayi B. O., Ayepola O. R., Egbeme E. E., Kolaviron, a natural antioxidant and anti-inflammatory phytochemical prevents dextran sulphate sodium-induced colitis in rats. Basic and Clinical Pharmacology and Toxicology 2013 113 1 49 55
23. Iwu M. M., Igboko O. A., Okunji C. O., Tempesta M. S., Antidiabetic and aldose reductase activities of biflavanones of Garcinia kola. Journal of Pharmacy and Pharmacology 1990 42 4 290 292 2-s2.0-0025288212
24. Benzie I. F. F., Strain J. J., The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Analytical Biochemistry 1996 239 1 70 76 2-s2.0-0030586361 10.1006/abio.1996.0292
25. Ou B., Hampsch-Woodill M., Prior R. L., Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. Journal of Agricultural and Food Chemistry 2001 49 10 4619 4626 2-s2.0-0034773950 10.1021/jf010586o
26. Singleton V. L., Orthofer R., Lamuela-Raventós R. M., Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent. Methods in Enzymology 1999 299 152 178 2-s2.0-0031790242 10.1016/S0076-6879(99)99017-1
27. Aebi H., Catalase in vitro. Methods in Enzymology 1984 105 121 126 2-s2.0-0021318441 10.1016/S0076-6879(84)05016-3
28. Crosti N., Servidei T., Bajer J., Serra A., Modification of the 6-hydroxydopamine technique for the correct determination of superoxide dismutase. Journal of Clinical Chemistry and Clinical Biochemistry 1987 25 4 265 266 2-s2.0-0023195599
29. Ellerby L. M., Bredesen D. E., Measurement of cellular oxidation, reactive oxygen species, and antioxidant enzymes during apoptosis. Methods in Enzymology 2000 322 413 421 2-s2.0-0033942358
30. Khoschsorur G. A., Winklhofer-Roob B. M., Rabl H., Auer T., Peng Z., Schaur R. J., Evaluation of a sensitive HPLC method for the determination of malondialdehyde, and application of the method to different biological materials. Chromatographia 2000 52 3-4 181 184 2-s2.0-0033894990
31. Ayepola O. R., Chegou N. N., Brooks N. L., Oguntibeju O. O., Kolaviron, a Garcinia biflavonoid complex ameliorates hyperglycemia-mediated hepatic injury in rats via suppression of inflammatory responses. BMC Complementary and Alternative Medicine 2013 13, article 363
32. Yadav P., Sarkar S., Bhatnagar D., Lipid peroxidation and antioxidant enzymes in erythrocytes and tissues in aged diabetic rats. Indian Journal of Experimental Biology 1997 35 4 389 392 2-s2.0-0031110143
33. Huang C., Kim Y., Caramori M. L. A., Fish A. J., Rich S. S., Miller M. E., Russell G. B., Mauer M., Cellular basis of diabetic nephropathy: II. The transforming growth factor- β system and diabetic nephropathy lesions in type 1 diabetes. Diabetes 2002 51 12 3577 3581 2-s2.0-0036895640
34. Kim J. Y., Lee S. H., Song E. H., Park Y. M., Lim J.-Y., Kim D. J., Choi K.-H., Park S. I., Gao B., Kim W.-H., A critical role of STAT1 in streptozotocin-induced diabetic liver injury in mice: controlled by ATF3. Cellular Signalling 2009 21 12 1758 1767 2-s2.0-70349762427 10.1016/j.cellsig. 2009.07.011
35. Harrison S. A., Liver disease in patients with diabetes mellitus. Journal of Clinical Gastroenterology 2006 40 1 68 76 2-s2.0-33644888156 10.1097/01.mcg.0000190774.91875.d2
36. Zelko I. N., Mariani T. J., Folz R. J., Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radical Biology and Medicine 2002 33 3 337 349 2-s2.0-0036667555 10.1016/S0891-5849(02)00905-X
37. Jurkovič S., Osredkar J., Marc J., Molecular impact of glutathione peroxidases in antioxidant processes. Biochemia Medica 2008 18 2 162 174 2-s2.0-46649104948
38. Seven A., Güzel S., Seymen O., Civelek S., Bolayirli M., Uncu M., Burçak G., Effects of vitamin E supplementation on oxidative stress in streptozotocin induced diabetic rats: investigation of liver and plasma. Yonsei Medical Journal 2004 45 4 703 710 2-s2.0-4644305395
39. Hamden K., Carreau S., Jamoussi K., Miladi S., Lajmi S., Aloulou D., Ayadi F., Elfeki A., 1 α25 dihydroxyvitamin D3: therapeutic and preventive effects against oxidative stress, hepatic, pancreatic and renal injury in alloxan-induced diabetes in rats. Journal of Nutritional Science and Vitaminology 2009 55 3 215 222 2-s2.0-70349319476 10.3177/jnsv.55.215
40. Likidlilid A., Patchanans N., Peerapatdit T., Sriratanasathavorn C., Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients. Journal of the Medical Association of Thailand 2010 93 6 682 693 2-s2.0-77954498409
41. Kdziora-Kornatowska K. Z., Luciak M., Blaszczyk J., Pawlak W., Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without diabetic nephropathy. Nephrology Dialysis Transplantation 1998 13 11 2829 2832 2-s2.0-0031726771 10.1093/ndt/13.11.2829
42. Bandeira M., Guedes S., da Fonseca L. J., Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity. Oxidative Medicine and Cellular Longevity 2012 2012 13 819310 10.1155/2012/819310
43. Valko M., Leibfritz D., Moncol J., Cronin M. T. D., Mazur M., Telser J., Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry and Cell Biology 2007 39 1 44 84 2-s2.0-33749986298 10.1016/j.biocel.2006.07.001
44. Corradini E., Foglia P., Giansanti P., Gubbiotti R., Samperi R., Laganà A., Flavonoids: chemical properties and analytical methodologies of identification and quantitation in foods and plants. Natural Product Research 2011 25 5 469 495 2-s2.0-79952635473 10.1080/14786419.2010.482054
45. Farombi E. O., Nwaokeafor I. A., Anti-oxidant mechanisms of kolaviron: studies on serum lipoprotein oxidation, metal chelation and oxidative membrane damage in rats. Clinical and Experimental Pharmacology and Physiology 2005 32 8 667 674 2-s2.0-22644436005 10.1111/j.0305-1870.2005.04248.x
46. Farombi E. O., Abarikwu S. O., Adedara I. A., Oyeyemi M. O., Curcumin and kolaviron ameliorate di-n-butylphthalate-induced testicular damage in rats. Basic and Clinical Pharmacology and Toxicology 2007 100 1 43 48 2-s2.0-33846016250 10.1111/j.1742-7843.2007.00005.x
47. Betteridge J., Pickup J. C., Williams G., Lipid disorders in diabetes mellitus. Text Book of Diabetes 1997 2nd London, UK Blackwell Science 1 35
48. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., Quagliaro L., Ceriello A., Giugliano D., Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002 106 16 2067 2072 2-s2.0-0037109184 10.1161/01.CIR.0000034509.14906.AE
49. Elmarakby A. A., Sullivan J. C., Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovascular Therapeutics 2012 30 1 49 59 2-s2.0-84856247093 10.1111/j.1755-5922.2010.00218.x
50. Vadla G. P. A., Vellaichamy E., Beneficial effects of aminoguanidine against streptozotocin-induced pathological changes in diabetic mice kidney. Biomedicine & Preventive Nutrition 2012 3 3 221 226
51. Santilli F., Spagnoli A., Mohn A., Tumini S., Verrotti A., Cipollone F., Mezzetti A., Chiarelli F., Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria. Journal of Clinical Endocrinology and Metabolism 2001 86 8 3871 3876 2-s2.0-0034889879 10.1210/jc.86.8.3871
52. Tesch G. H., MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. American Journal of Physiology-Renal Physiology 2008 294 4 F697 F701 2-s2.0-44949130856 10.1152/ajprenal.00016.2008
53. Palsamy P., Subramanian S., Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochimica et Biophysica Acta 2011 1812 7 719 731 2-s2.0-79955634116 10.1016/j.bbadis.2011.03.008
54. Takahashi H., Shibuya M., The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clinical Science 2005 109 3 227 241 2-s2.0-25144511910 10.1042/CS20040370
55. Chiarelli F., Spagnoli A., Basciani F., Tumini S., Mezzetti A., Cipollone F., Cuccurullo F., Morgese G., Verrotti A., Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with type 1 diabetes mellitus: relation to glycaemic control and microvascular complications. Diabetic Medicine 2000 17 9 650 656 2-s2.0-0033782589 10.1046/j.1464-5491.2000.00350.x
56. Chen S., Ziyadeh F. N., Vascular endothelial growth factor and diabetic nephropathy. Current Diabetes Reports 2008 8 6 470 476 2-s2.0-63149094688 10.1007/s11892-008-0081-3
57. Xing L., Remick D. G., Promoter elements responsible for antioxidant regulation of MCP-1 gene expression. Antioxidants and Redox Signaling 2007 9 11 1979 1989 2-s2.0-35448988491 10.1089/ars.2007.1921
58. Lefer D. J., Granger D. N., Monocyte rolling in early atherogenesis vital role in lesion development. Circulation Research 1999 84 11 1353 1355 2-s2.0-0033546076
59. Egashira K., Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1. Hypertension 2003 41 3 834 841 2-s2.0-0037341813 10.1161/01.HYP.0000051642.65283.36
60. Chow F. Y., Nikolic-Paterson D. J., Ozols E., Atkins R. C., Rollin B. J., Tesch G. H., Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney International 2006 69 1 73 80 2-s2.0-30944456936 10.1038/sj.ki.5000014